Treating pancreatic cancer: more antioxidants more problems?

Expert Rev Gastroenterol Hepatol. 2018 Sep;12(9):849-851. doi: 10.1080/17474124.2018.1494572. Epub 2018 Jul 5.
No abstract available

Publication types

  • Editorial
  • Review

MeSH terms

  • Antineoplastic Agents / therapeutic use*
  • Antioxidants / metabolism
  • Antioxidants / therapeutic use*
  • Carcinoma, Pancreatic Ductal / genetics
  • Carcinoma, Pancreatic Ductal / metabolism
  • Carcinoma, Pancreatic Ductal / pathology
  • Carcinoma, Pancreatic Ductal / therapy*
  • Dietary Supplements*
  • Genetic Therapy / methods*
  • Glutathione Peroxidase / genetics
  • Glutathione Peroxidase / metabolism
  • Humans
  • Molecular Targeted Therapy
  • NF-E2-Related Factor 2 / genetics
  • NF-E2-Related Factor 2 / metabolism
  • Oxidation-Reduction
  • Oxidative Stress* / drug effects
  • Oxidative Stress* / genetics
  • Pancreatic Neoplasms / genetics
  • Pancreatic Neoplasms / metabolism
  • Pancreatic Neoplasms / pathology
  • Pancreatic Neoplasms / therapy*
  • Signal Transduction / drug effects
  • Signal Transduction / genetics
  • Superoxide Dismutase / genetics
  • Superoxide Dismutase / metabolism
  • Treatment Outcome

Substances

  • Antineoplastic Agents
  • Antioxidants
  • NF-E2-Related Factor 2
  • NFE2L2 protein, human
  • Glutathione Peroxidase
  • Superoxide Dismutase